Floatz logo

11c-sarcosine

Schizophrenias

Chang-Hua HospitalradiopharmaceuticalPhase 2Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Schizophrenias cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

11c-sarcosine is also rated in:

Major Depressive DisorderDormant
B
Indicative ·
63 / 100
View asset →
PsychosesDormant
B
Indicative ·
62 / 100
View asset →
DepressionDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →